Diaceutics PLC

Diaceutics PLC

Pharmaceutical Manufacturing

Belfast, Northern Ireland 16,594 followers

Better Testing, Better Treatment

About us

At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®. DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories.

Industry
Pharmaceutical Manufacturing
Company size
51-200 employees
Headquarters
Belfast, Northern Ireland
Type
Public Company
Founded
2005
Specialties
Personalized medicine planning and corporate strategy, Comprehensive commercial planning in personalized medicine, Optimizing return on investment in personalized medicine, Leveraging diagnostics to enhance value in personalized medicine, Understanding the diagnostic landscape, Diagnostic development and commercialization service provision, Test implementation in treatment pathways, and Driving better testing to enable better treatment decisions for patients

Locations

  • Primary

    First floor, Building Two, Dataworks at Kings Hall Health and Wellbeing Park

    Belfast, Northern Ireland BT9 6GW, GB

    Get directions
  • 2001 Route 46 East

    The Metropolis Tower 2

    Parsippany, New Jersey 07054, US

    Get directions
  • Creative Spark

    Clontygora Ct, Muirhevnamore

    Dundalk, Co. Louth A91 HF77, IE

    Get directions
  • 1 Harbourfront Avenue

    #14-08 Keppel Bay Tower

    Singapore, Singapore 098632, SG

    Get directions

Employees at Diaceutics PLC

Updates

  • View organization page for Diaceutics PLC, graphic

    16,594 followers

    Today, Diaceutics celebrated World Mental Health Day with a Mindfulness and Guided Meditation Workshop held by Vita Wellness at our DataWorks Belfast HQ and streamed online for our remote employees across 16 different countries. This year’s theme, set by the World Federation of Mental Health, is Workplace Mental Health. Work is such a large part of many people’s lives and as a result, our work environment plays a significant role in shaping our mental health.    At Diaceutics we want to ensure our people’s wellbeing can flourish and everyone can thrive at work and life. This is not a standalone initiative; we strive to continue to support our people every day through creating great working experiences as well as creating programs and enhancing policies that support wellbeing.   "I truly believe that our wellbeing is the very foundation of our capacity to perform. Very simply, our energy directly impacts our engagement and productivity and we cannot be energized if we are not healthy. Employers have a unique opportunity to create supportive work environments that promote mental wellbeing, ultimately benefiting the lives of our people and our business outcomes. At Diaceutics we are committed to creating a healthy working environment that gives our people a source of purpose, connection and growth. Let’s keep the conversation going not just today, but every day!" Sandra Blake, Chief People Officer #WorldMentalHealthDay #MentalHealth #MentalWellBeing

    • No alternative text description for this image
  • View organization page for Diaceutics PLC, graphic

    16,594 followers

    Today’s the day! Join us today for the next webinar in The Precision Medicine Webinar Series, “Harnessing Real-World Data for Strategic Provider Targeting and Early Patient Identification in Precision Medicine” from 1-2 PM EDT. Don’t miss the chance to hear from Kelly Williams, our VP of Insight Solutions, as she shares innovative approaches  for transforming the commercialization of precision medicines. Understand the importance of accurately identifying physicians with treatment-eligible patients early in their healthcare journey, and discover effective strategies for segmenting providers to enhance your field force planning and maximize efficiency. It’s not too late to register—secure your spot using the link below! https://lnkd.in/ep--Jn6f #PrecisionMedicine #Webinar #HealthcareInnovtion

    • No alternative text description for this image
  • View organization page for Diaceutics PLC, graphic

    16,594 followers

    Just one day to go until our next webinar in The Precision Medicine Webinar Series, “Harnessing Real-World Data for Strategic Provider Targeting and Early Patient Identification in Precision Medicine" on Thursday, 10th October, from 1-2pm EDT. Don't miss this opportunity to hear from our VP of Insight Solutions, Kelly Williams. Discover innovative approaches for transforming the commercialization of precision medicines, gain valuable insight on using real-world data to accurately identify physicians with treatment-eligible patients early in their healthcare journey, and learn effective strategies for segmenting providers to enhance your field force planning and maximize efficiency. Register today using the link below: https://lnkd.in/ep--Jn6f #PrecisionMedicine #Webinar #HealthcareInnovtion

    • No alternative text description for this image
  • View organization page for Diaceutics PLC, graphic

    16,594 followers

    We are back with another LabTalk! We will be joined by Prof. Pruneri who will be discussing: “Biomarker Testing for Antibody-drug-conjugates (ADCs) in cancer patients” Sign up now - https://lnkd.in/ezU6jJ5E    ADCs are rapidly advancing and have shown promising results in cancer treatment. Prof Pruneri, Full Professor of Pathology at the University of Milan and Chair of the Department of Advanced Diagnostics (Milan National Cancer Institute), will share the status of ADC use in cancer treatment. Join us on Tuesday 29th October, 2.30pm CET for expert insights! Sign up to DXRX today to be notified about all upcoming LabTalks - https://lnkd.in/enF9nuCf

  • View organization page for Diaceutics PLC, graphic

    16,594 followers

    Are you struggling to adopt a highly efficient and precise strategy for targeting and engaging providers? Join us this Thursday, 10th October, from 1-2pm EDT for our webinar, “Harnessing Real-World Data for Strategic Provider Targeting and Early Patient Identification in Precision Medicine.” Discover innovative approaches for transforming the commercialization of precision medicines, gain valuable insight on using real-world data to accurately identify physicians with treatment-eligible patients early in their healthcare journey, and learn effective strategies for segmenting providers to enhance your field force planning and maximize efficiency. Register today using the link below: https://lnkd.in/ep--Jn6f #PrecisionMedicine #Webinar #HealthcareInnovtion

    • No alternative text description for this image
  • View organization page for Diaceutics PLC, graphic

    16,594 followers

    The countdown is on! Just one week to go until our webinar, “Harnessing Real-World Data for Strategic Provider Targeting and Early Patient Identification in Precision Medicine.” Join us on October 10th, from 1-2pm EDT to discover innovative approaches for transforming the commercialization of precision medicines, gain insight on how to leverage real-world data to accurately identify physicians with treatment-eligible patients early in their healthcare journey, and learn strategies for segmenting providers to optimize your field force planning. Register today using the link below: https://lnkd.in/ep--Jn6f #PrecisionMedicine #Webinar #HealthcareInnovtion

    • No alternative text description for this image
  • View organization page for Diaceutics PLC, graphic

    16,594 followers

    Are you struggling to identify eligible patients for your precision medicine therapy?   In today’s precision medicine landscape, where access to providers is limited and pharma field forces are reduced, it is crucial to adopt a highly efficient and precise strategy for targeting and engaging with providers. Join us on October 10th, 1-2pm EDT for our next webinar in The Precision Medicine Series, “Harnessing Real-World Data for Strategic Partner Targeting and Early Patient Identification in Precision Medicine.” Discover innovative approaches for transforming the commercialization of precision medicines, gain insight on how to leverage real-world data to accurately identify physicians with treatment-eligible patients early in their healthcare journey, and discover strategies for segmenting providers to optimize your field force planning.   Register today: https://lnkd.in/ep--Jn6f   #PrecisionMedicine #Webinar #HealthcareInnovtion  

  • View organization page for Diaceutics PLC, graphic

    16,594 followers

    Exciting times ahead for Diaceutics as we are featured on the front page of the Business section of The Irish News, discussing our future growth aspirations following recent successes. As our CEO, Ryan Keeling states, “With 90% of our revenue generated in the US, floating on NASDAQ is certainly on our radar and a potential aspiration”. This reflects our ongoing commitment to expanding our presence and capabilities to better serve our customers and stakeholders. Read the full article here: https://lnkd.in/eT-q4rFi #Diaceutics #Innovation #Growth #NASDAQ #PrecisionMedicine  

    • No alternative text description for this image
  • View organization page for Diaceutics PLC, graphic

    16,594 followers

    2024 marks the 30th anniversary of the discovery of ALK as a biomarker. From its initial identification in 1994 to its pivotal role in transforming cancer therapies, ALK has revolutionized cancer treatment. Over the past three decades, ALK-targeted therapies have provided hope and extended lives for countless patients. From the groundbreaking approval of crizotinib in 2011 to the development of advanced inhibitors like alectinib and lorlatinib, the journey of ALK has been transformative. At Diaceutics, we are committed to ensuring every patient receives the right treatment at the right time. By leveraging our extensive real-world datasets and deep understanding of diagnostic pathways, we enable our pharma partners to identify and treat patients with ALK rearrangements effectively.  We look forward to the future of ALK-targeted therapies and continued advancements in precision medicine. Here’s to 30 years of innovation and many more breakthroughs ahead! Read our latest article to look back on the last 30 years of ALK and how the future looks for this important biomarker.  https://lnkd.in/gxiu2R3z #PrecisionMedicine #ALK #CancerResearch #Diaceutics #HealthcareInnovation #NSCLC   

    • No alternative text description for this image
  • View organization page for Diaceutics PLC, graphic

    16,594 followers

    As Blood Cancer Awareness Month comes to an end, we want to thank you for your participation! Whether that is joining one of our captivating LabTalks, engaging with our content or if you’ve decided to become a DXRX member. In case you missed it, you can catch up on all our Blood Cancer content and LabTalks here: https://lnkd.in/eF_7tDiW Join DXRX and stay up to date with the latest Blood Cancer related insights. https://lnkd.in/enF9nuCf #BloodCancerAwarenessMonth

Similar pages

Browse jobs

Funding

Diaceutics PLC 2 total rounds

Last Round

Post IPO debt

US$ 5.3M

See more info on crunchbase